BioSpace News Archive

Under a three-year agreement, Excelra – a leading global data and analytics company – will provide Lawrence Livermore National Laboratory (LLNL) with GOSTAR, a small molecule medical chemistry intelligence database to aid drug design projects

Doctor Evidence (DRE), a leading Artificial Intelligence-powered SaaS healthcare insights company, has launched its revolutionary DOC (“Digital Outcome Conversion”) Analytics™ platform.

Amwell®, a national telehealth leader, announced that it has been named the “Best Overall Telehealth Solution” by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market.

Aetion has signed a research collaboration agreement with the U.S. Food and Drug Administration (FDA) to use real-world data to advance the understanding of and response to coronavirus disease (COVID-19).

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that the distribution of the previously announced Hoth Therapeutics, Inc. (“Hoth”) stock dividend, has commenced and stockholders will receive their dividend in the next few days by mail or electronic deposit.

Advanced ICU Care, the nation’s leading provider of high-acuity tele-ICU and monitoring services, has been honored by MedTech Breakthrough with recognition for offering the “Best Remote Patient Monitoring Solution”.

The Bio-Process Systems Alliance (BPSA), the international association of the single-use bio-processing industry, is pleased to announce the release of its new technical guide: 2020 Recommendations for Testing, Evaluation, and Control of Particulates from Single-Use Processing Equipment

AusculSciences™, a pioneer in developing advanced bioacoustic technologies to detect cardiovascular and pulmonary conditions, today announced that it is developing the Auscul-X™ Touchless Stethoscope System which will allow physicians and nurses to listen to heart and lung sounds at a safe distance from patients with diagnosed or suspected infectious diseases such as COVID-19.

Voltron Therapeutics, Inc. announces today a letter to the shareholders. Dear Voltron Therapeutics shareholders, We hope this letter finds you well during this remarkable time. We would also like to thank for your support of Voltron. The current COVID-19 pandemic is exactly the kind of situation that our VaxCelerate platform was cr

Today, NanoVapor Biotech, a division of NanoVapor Inc., announces a newly formed Executive Advisory team to address innovation in pandemic mitigation using nanotechnology on an industrial scale.